Prefilled Syringes Market Report

Global Prefilled Syringes Market Size

The prefilled syringes market globally was valued at USD 5.99 billion in 2025, projected to expand to USD 6.63 billion in 2026, and touch USD 14.95 billion by 2034, at a CAGR of 10.7%.

The prefilled syringes are disposable syringes that are already loaded with the drug to be injected to avoid cases of overfill. The global prefilled syringes market has been experiencing prominent growth in recent periods due to the prevalence of chronic disease conditions requiring injectable medications. According to reports, in 2023, in the U.S., will close to 133 million individuals will suffer from one or more chronic disorders, and the number is likely to reach 170 million by 2030. The prefilled syringes will reduce the dosage errors and wastage of the expensive drug product, as it was loaded during manufacturing and can be used only for a single purpose. Prefilled syringes provide excellent patient safety by reducing the cases of needle sticks and toxic product exposure. Various advantages of prefilled syringes, like convenience to use, affordability, accuracy with sterility, andsafetyt,y enhance the adoption of these syringes over conventional ones, further accelerating the market growth. The continuous R&D activities by the market players in introducing effective and safe products and government support initiatives will create market growth opportunities in the coming years. Over 40% of the major pharmaceutical companies have prefilled syringe manufacturing facilities across Asia Pacific, Europe, and North America.

MARKET DRIVERS

The rising demand for self-medication is one of the key factors driving the prefilled syringes market growth.

The aging population is growing rapidly worldwide, and the population suffering from chronic diseases such as diabetes is also increasing at an exponential rate globally. These people are more likely to take regular care to stay on the healthy side. Many patients affected by chronic diseases benefit from prefilled syringes, as there is a need for continuous medication for chronic diseases. The total availability and increasing use of single-cavity prefilled syringes are key factors driving the growth of the global prefilled syringes market. Furthermore, the healthcare industry has witnessed chronic diseases such as cardiovascula diseaser, cancer, respiratory disease, and diabetes due to lifestyle changes and the lack of preventive care opportunities, especially in developing countries. Therefore, it is merely to boost the prefilled syringes market growth. The governments have started focusing on prefilled syringes for palliative benefits. These prefilled syringes are mainly used for people suffering from chronic diseases and are under palliative care. Increasing ulcerative colitis (UC) disorder also drives the use of prefilled syringes. It is a chronic disease that affects the bowel through continuous inflammation. The healthcare industries have witnessed the prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer in developing countries. Therefore, it has boosted the market demand for prefilled syringes. Devices like pen injection are one of the significant selling products in prefilled syringes.

In addition, the development of technologically advanced prefilled syringes and the growing demand for self-injection devices propel the prefilled syringes market growth. Increasing production of prefilled syringes by several pharmaceutical companies will also drive the market in the coming years. Factors such as minimizing drug waste, increasing product life span, convenient drug administration, using prefilled syringes in hospitals and homes, and reducing healthcare providerneedsd drive the prefilled syringe market every time. It also reduces the toxin that occurs when drawing the medication from the vials, and it also reduces dosage errors.

MARKET RESTRAINTS

However, certain complexities associated with the primary packaging, such as drug reaction, may affect the prefilled syringes market growth to a certain extent. The response to plastic also affects the quality of the drugs, hampering the market growth. Using glass prefilled syringes also restrained the market growth. These Glass prefilled syringes may get broken during transportation or slip from hand. A lack of awareness about these prefilled syringes also hinders the market growth. In low-developed countries, prefilled syringe use is low due to a lack of awareness and fear of using their own. Limited time for storing these prefilled syringes, based on the disease type,e also hampers the market growth.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Material Insights

The glass prefilled syringes segment is estimated to account for the most significant global market share during the forecast period. An increasing number of people suffering from chronic diseases is a significant factor for this segment to grow. Glass syringes are approved by the FDA and follow the International Organization for Standardization Standard. Glass's protective properties prevent oxygen and water vapor from combining with drug compounds. Glass is mainly used for prefilled syringes, which drives the segment's growth. In addition, increasing support from government organizations is propelling segmental growth.

By Type Insights

The safety prefilled syringes segment is estimated to showcase a promising CAGR over the forecast period. The growing disposable income and the rising prevalence of innovative products in healthcare are fuelling segmental growth. As a result, the safety prefilled syringes segment is predicted to have the fastest growth rate in the forecast period.

By Design Insights

The single chamber segment held the largest share of the worldwide market in 2023 and is expected to hold a dominating position during the forecast period. Single-chamber prefilled syringes protect patients and clinicians from needle stick injuries and augment segmental growth. In addition, the simple storage and easy usage of a single-chamber design is another notable factor contributing to the segment's growth.

The dual-chamber segment is predicted to grow at 12% CAGR during the forecast period. The dual-chamber design allows solvents and ingredients to be separately filled. As the dual chamber design gives excellent medication storage and delivery, its demand will rise in the coming years.

By Application Insights

The monoclonal antibodies segment is estimated to occupy a major global market share during the forecast period. Nowadays, monoclonal antibody (mAb) therapies are primarily used to treat various diseases like cancer and autoimmune disorders. Therefore, most mAb drug products are sold as prefilled syringes of different dosages.

By Distribution Channel Insights

The hospital segment accounted for the largest worldwide market share in 2023 based on the distribution channel. Factors such as the rising patient population suffering from chronic diseases, admitted in the hospital,s, and increasing health disorders requiring long-term treatment are fuelling the segmental growth. In addition, growing cancer and diabetes in patients are likely to result in the segment's growth rate.

The ambulatory surgical centers segment is expected to grow rapidly during the forecast period. Prefilled syringes are also used for patients admitted to the ambulatory surgical center for same-day treatment for a small operation.

REGIONAL ANALYSIS

Europe accounted for the most significant share of the global market in 2023.

New manufacturing facilities will be started in the European region in the coming years, increasing the market expansion in this region. They focus on manufacturing different types of prefilled syringes for different diseases. In addition, most researchers focus on innovatively designing the device to reduce patient risk. As a result, the use of ready-to-use prefilled syringes is increasing during the forecast period.

North America is another potential regional segment in the global market.

North America is estimated to grow at a healthy CAGR during the forecast period. Due to the increase in the prevalence of diabetes and autoimmune diseases, the aging population vulnerable to chronic diseases, further supports the increase in incidence. Medicines and biologics approved for treating these diseases should be given in prefilled syringes, contributing to market development in this region. The increasing aging population, lack of staff shortages, and increased healthcare awareness among people in the U.S are the factors that drive the prefilled syringe market forward. In America, the number of older people aged above 60 will have doubled by 2050. In addition, most people are using home therapies that need to be treated by healthcare providers or caretakers. For these people, these prefilled syringes are used to manage their taking ofan overdose of the drug, increasing patient confidence by taking syringes from anyone who cannot know about this drug prescription.

The Asia-Pacific region is estimated to register the fastest CAGR in the global market.

India and China have vast pools of diabetic patients, and many remain undiagnosed. In addition, sedentary lifestyles and unhealthy eating habits can be associated with the increasing incidence of autoimmune and chronic diseases. As a result, the unsatisfactory demand for superior drug delivery systems is widespread in the region. Besides, the increase in disposable income in the area and the development of health infrastructure will accelerate the use of prefilled syringes during the forecast period.

The prefilled syringes market in Latin America is anticipated to hold a considerable share of the global market during the forecast period. In Brazil, about 12.5 million people have diabetes. In addition, nearly 88,000 children and adolescents have type 1 diabetes, making it the country with the world's third-highest number of children with diabetes. Therefore, market players in this region manufacture prefilled syringes for diabetes and other chronic diseases to improve patients' lives.

The MEA prefilled syringes market is expected to grow at a moderate CAGR in the coming years.

KEY MARKET PLAYERS

Some of the prominent companies operating in the global prefilled syringes market profiled in the report are

Becton, Dickinson, and Company (U.S.), Gerresheimer AG (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany), and Nipro Corporation Japan) and MedPro Inc. (U.S.).

RECENT HAPPENINGS IN THIS MARKET

• In 2021, the Serum Institute of India joined the Indian packaging joint venture SCHOTT Kaisha to manufacture many syringes and vials and make them with secure pharmaceutical packaging to meet the demand during the pandemic.
• In 2021, Packaging Nipro Pharma CURACASE started packing needles individually in compact and smartly designed hard-plastic packaging, reducing the space in secondary packaging.
• In 2021, West Pharmaceutical Services, Inc. started a NovaGuard® SA Pro Safety System with the launch of a 0.5mL Standard Syringe Device in India for a single-use product.
• In June 2019, Fresenius Kabi introduced the neostigmine methyl sulfate infusion, USP Simplist prefilled syringe, in the United States.

MARKET SEGMENTATION

This research report on the global prefilled syringes market has been segmented and sub-segmented based on the material, type, design, application, distribution channel, and region.

By Material

• Glass Prefilled Syringes
• Plastic Prefilled Syringes

By Type

• Conventional
• Safety

By Design

• Single-Chamber
• Dual-Chamber

By Application

• Vaccines
• Monoclonal Antibodies

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Mail-Order Pharmacies

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa